Want to Cash in on the Marijuana Boom? My Top Cannabis Stock to Buy in June

Buy Colombian cannabis cultivator PharmaCielo Ltd. (TSXV:PCLO) today before it soars.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Cannabis stocks have come off the boil since the start of 2019 and there appears to be little life left in the sector as fears of a trade war and a weaker global economy weigh on the outlook for consumer products. This is being exacerbated by growing fears that marijuana stocks are in a bubble and many are heavily overvalued.

While Canadian industry leaders such as Canopy Growth and Aurora Cannabis have soared by around 58% and 45%, respectively since the start of 2019, many smaller plays have failed to make the same gains. Leading Colombian cannabis cultivator PharmaCielo (TSXV:PCLO) has made nowhere near those gains, rising by just 26% over that period and losing 4% over the last year, creating an opportunity for risk-tolerant investors seeking speculative exposure to the global cannabis industry.

Leading South American cultivator

PharmaCielo is the industry-leading legal marijuana cultivator in Colombia, giving it a first mover advantage in a country that could easily become the Saudi Arabia of cannabis. The equatorial nation’s unique geography, geology and climate has long viewed it as a rich source of agricultural products including fruits and cut flowers.

Those characteristics coupled with clear regulation, a deep pool of skilled labour, low start-up costs, world famous Colombia cannabis strains and low operational costs because cultivation in open-air greenhouses is realistic. That gives Colombia a significant comparative advantage over many North American jurisdictions, especially Canada, where cannabis companies are typically required to engage in extremely costly climate controlled indoor cultivation.

PharmaCielo recently announced that it would acquire Australian listed medicinal marijuana company Creso Pharma (ASX:CPH) for approximately $111 million in an all-stock deal. Creso owns licenced cannabis cultivation facilities in Canada, where it harvested its first marijuana crop in late May and is developing additional cultivation assets in Colombia and Israel.

It is focused on the production of marijuana edibles, topicals and other extract-based products with distribution agreements in the U.K., Switzerland and Australia.

The deal has been unanimously recommended by the Creso Board of Directors, and if approved by shareholders will be beneficial for both companies. It will scale up PharmaCielo’s Colombian acreage and boost its distribution channels, particularly in Europe, while giving it an operational growing facility in Canada.

Creso has a 24,000 square foot indoor cultivation facility in Nova Scotia that can produce 4,000 kilograms of cannabis annually and can be expanded to produce up to 10 times that amount. This positions PharmaCielo to start generating revenue and take advantage of the upcoming legalization of marijuana edibles, extracts and topicals in Canada, while continuing to develop its Colombian operations.

Given the low start-up and operating costs compared to Canada, Colombia offers the best long-term prospects. Some industry analysts have estimated that it costs less than a fifth of what it costs in Canada to produce a gram of dried flower in the equatorial nation.

Coupled with premium prices in Canada and other developed jurisdictions where its use is legalized in one form or another, it’s easy to see how PharmaCielo can benefit from cultivating and processing its marijuana in Colombia while selling it in Canada.

Putting it together for investors

PharmaCielo has 15 million square feet of available cultivation capacity in Colombia.

It is composed of a 1.3 million square foot nursery and propagation centre along with 0.4 million square feet of greenhouses in Rio Negro, a satellite city of Medellin, and 13.3 million square feet of land for cultivation with contract growers. The company is also constructing a US$5 million research, technology and processing centre that once complete will need to be certified by the Colombian National Food and Drug Surveillance Institute.

Once they are fully online, those facilities along with the additional Creso assets will give PharmaCielo’s earnings a solid boost, which in turn will give its stock a healthy lift.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Matt Smith has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Fire & Flower: A Small Pot Stock Poised for Strong Growth

Fire & Flower is a cannabis retailer well-positioned for growth thanks to its digital and delivery initiatives.

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Is Sinking This Week

Starting another round of capital raising has hurt investor sentiments, and the Canadian cannabis giant’s performance on the stock market…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Canopy Growth (TSX:WEED) Stock Plunged 19% Last Week

Canopy Growth Corp. (TSX:WEED)(NASDAQ:CGC) stock has plunged after the release of its final fiscal 2022 results.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Tanked 45% Last Week

There's no respite for Aurora Cannabis investors!

Read more »

Money growing in soil , Business success concept.
Cannabis Stocks

TFSA Investors: This Undervalued Gem Could Turn $6,000 Into $25,000

Here's why TFSA investors can hold undervalued growth stocks such as Verano in their portfolios right now.

Read more »